Evidence map›Paper›PMID 40532872›Full record

ArticleThe journal of allergy and clinical immunology. In practice2025

Rapid rise in unspecified mast cell activation diagnosis code usage in the United States.

Stefani Aleman, Ollie Anna Bystricky, Dominique Denbow, Mildred Kwan, Evan S Dellon, Onyinye I Iweala

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. In practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stefani AlemanCenter for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, NC.
Ollie Anna BystrickyAllergy Mast Cell Disorders Program, University of North Carolina School of Medicine, Chapel Hill, NC; Division of Rheumatology, Allergy, and Immunology, Thurston Arthritis Research Center, University of North Carolina School of Medicine, Chapel Hill, NC.
Dominique DenbowAllergy Mast Cell Disorders Program, University of North Carolina School of Medicine, Chapel Hill, NC; Division of Rheumatology, Allergy, and Immunology, Thurston Arthritis Research Center, University of North Carolina School of Medicine, Chapel Hill, NC.
Mildred KwanAllergy Mast Cell Disorders Program, University of North Carolina School of Medicine, Chapel Hill, NC; Division of Rheumatology, Allergy, and Immunology, Thurston Arthritis Research Center, University of North Carolina School of Medicine, Chapel Hill, NC; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.
Evan S DellonCenter for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, NC; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC; Division of Gastroenterology and Hepatology, Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC.
Onyinye I IwealaAllergy Mast Cell Disorders Program, University of North Carolina School of Medicine, Chapel Hill, NC; Division of Rheumatology, Allergy, and Immunology, Thurston Arthritis Research Center, University of North Carolina School of Medicine, Chapel Hill, NC; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC. Electronic address: onyinye.iweala@med.unc.edu.

Funding

PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Temitope O. Keku · 1985 to 2026
$30.5M
SHORT-TERM RESEARCH TRAININGT35DK007386 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Evan Samuel Dellon · 1986 to 2026
$4.1M
A role for glycolipids and unconventional T cell subsets in alpha-gal allergyK08AI141691 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI IWEALA, ONYINYE I · 2020 to 2024
$998k
NIAID NIH HHS K08 AI141691NIDDK NIH HHS P30 DK034987NIDDK NIH HHS T35 DK007386
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40532872
PMCPMC12439097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.